These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3952742)
1. Electromyographic, neuropathologic, and functional correlates in the cat as the result of tri-o-cresyl phosphate delayed neurotoxicity. Abou-Donia MB; Trofatter LP; Graham DG; Lapadula DM Toxicol Appl Pharmacol; 1986 Mar; 83(1):126-41. PubMed ID: 3952742 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of the cat to delayed neurotoxicity induced by O-ethyl O-4-nitrophenyl phenylphosphonothioate. Abou-Donia MB; Graham DG; Kinnes CG Toxicol Appl Pharmacol; 1983 Mar; 68(1):54-65. PubMed ID: 6845375 [TBL] [Abstract][Full Text] [Related]
4. Brain acetylcholinesterase, acid phosphatase, and 2',3'-cyclic nucleotide-3'-phosphohydrolase and plasma butyrylcholinesterase activities in hens treated with a single dermal neurotoxic dose of S,S,S-tri-n-butyl phosphorotrithioate. Abou-Donia MB; Abdo KM; Timmons PR; Proctor JE Toxicol Appl Pharmacol; 1986 Mar; 82(3):461-73. PubMed ID: 3952729 [TBL] [Abstract][Full Text] [Related]
5. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409 [TBL] [Abstract][Full Text] [Related]
6. Disposition of [14C]tri-o-cresyl phosphate and its metabolites in various tissues of the male cat following a single dermal application. Nomeir AA; Abou-Donia MB Drug Metab Dispos; 1984; 12(6):705-11. PubMed ID: 6150819 [TBL] [Abstract][Full Text] [Related]
7. The effects of drug metabolism inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in hens following a single intravenous administration. Konno N; Katoh K; Yamauchi T; Fukushima M J Toxicol Sci; 1988 Feb; 13(1):17-30. PubMed ID: 3385808 [TBL] [Abstract][Full Text] [Related]
8. Lack of delayed neurotoxic effect after tri-o-cresyl phosphate treatment in male Fischer 344 rats: biochemical, neurobehavioral, and neuropathological studies. Somkuti SG; Tilson HA; Brown HR; Campbell GA; Lapadula DM; Abou-Donia MB Fundam Appl Toxicol; 1988 Feb; 10(2):199-205. PubMed ID: 3356306 [TBL] [Abstract][Full Text] [Related]
9. Time-dependent changes of lipid peroxidation and antioxidative status in nerve tissues of hens treated with tri-ortho-cresyl phosphate (TOCP). Zhang LP; Wang QS; Guo X; Zhu YJ; Zhou GZ; Xie KQ Toxicology; 2007 Sep; 239(1-2):45-52. PubMed ID: 17662514 [TBL] [Abstract][Full Text] [Related]
10. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Distribution, excretion, and metabolism in male cats after a single, dermal application. Nomeir AA; Abou-Donia MB Toxicology; 1986 Jan; 38(1):15-33. PubMed ID: 3942008 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous toxicity and delayed neurotoxicity of organophosphates in the scaleless hen. Cisson CM; Wilson BW Toxicol Appl Pharmacol; 1983 Mar; 67(3):310-21. PubMed ID: 6845361 [TBL] [Abstract][Full Text] [Related]
17. Acute delayed neurotoxicity in hens dosed with tri-ortho-cresyl phosphate (TOCP): correlation between clinical ataxia and neuropathological findings. Prentice DE; Roberts NL Neurotoxicology; 1983; 4(2):271-6. PubMed ID: 6685266 [No Abstract] [Full Text] [Related]
18. Assessment of the delayed neurotoxic potential of isopropyl triphenylphosphate using a nontraditional testing strategy. Sprague GL; Castles TR; Bickford AA J Toxicol Environ Health; 1984; 14(5-6):773-88. PubMed ID: 6520887 [TBL] [Abstract][Full Text] [Related]